BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Bank of America Merrill Lynch
|Target Hit|| Long (1Y)
Bank of America Merrill Lynch maintains buy on Sun Pharma
Doxil supply shortage can continue till end of 2014 and will benefit Sun Pharma as sole supplier. Raise earnings by 3.5-4 per cent. Target at Rs 650.